Flunarizine showed no clear difference in death or dependency at end of compared with placebo (low certainty).
Flunarizine showed no clear difference in death at the end of treatment compared with placebo (low certainty).
Flunarizine may leads to higher death at the end of compared with placebo (low certainty).
Flunarizine showed no clear difference in recurrence of stroke at the end of compared with placebo (low certainty).
Flunarizine may leads to higher adverse events during treatment period compared with placebo (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Flunarizine showed no clear difference in 50% or greater reduction in seizure frequency Number of seizures compared with placebo (high certainty).
Flunarizine probably leads to higher treatment withdrawal Number of withdrawals compared with placebo (moderate certainty).
Flunarizine showed no clear difference in adverse effects ‐ Blurred vision No of patients with blurred vision compared with placebo (high certainty).
Flunarizine showed no clear difference in adverse effects ‐ Dizziness No of patients with dizziness compared with placebo (high certainty).
Flunarizine showed no clear difference in adverse effects ‐ Fatigue No of patients with fatigue compared with placebo (high certainty).
Flunarizine showed no clear difference in adverse effects ‐ Irritability No of patients with irritability compared with placebo (high certainty).
Flunarizine showed no clear difference in adverse effects ‐ Vomiting No of patients with vomiting compared with placebo (high certainty).